PHASE I/IB STUDY OF LONAFARNIB AND TEMOZOLOMIDE IN PATIENTS WITH RECURRENT OR TEMOZOLOMIDE REFRACTORY GLIOBLASTOMA

被引：0
|
作者：
Yust-Katz, Shlomit [1 ]
Liu, Vivian [1 ]
Sanghee, Kang [1 ]
Groves, Moriss [1 ]
Puduvalli, Vinay [1 ]
Levin, Victor [1 ]
Conrad, Charles [1 ]
Colman, Howard [2 ]
Hsu, Sigmund [1 ]
Yung, Alfred W. [1 ]
Gilbert, Mark R. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Univ Utah, Salt Lake City, UT USA
来源：
NEURO-ONCOLOGY | 2012年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：68 / 68
页数：1
相关论文
共 50 条
  • [31] A PHASE II TRIAL OF SORAFENIB (NEXAVAR) AND PROTRACTED TEMOZOLOMIDE FOR PATIENTS WITH RECURRENT GLIOBLASTOMA
    Reardon, David
    Desjardins, Annick
    Vredenburgh, James
    Friedman, Allan
    Sampson, John
    Gururangan, Sridharan
    Rich, Jeremy
    Friedman, Henry
    NEURO-ONCOLOGY, 2008, 10 (05) : 839 - 839
  • [32] Salvage chemotherapy with cyclophosphamide for recurrent, temozolomide-refractory glioblastoma multiforme
    Chamberlain, MC
    Tsao-Wei, DD
    CANCER, 2004, 100 (06) : 1213 - 1220
  • [33] Combined chemotherapy with temozolomide and fotemustine in recurrent glioblastoma patients
    Gaviani, Paola
    Salmaggi, A.
    Silvani, A.
    JOURNAL OF NEURO-ONCOLOGY, 2011, 104 (02) : 617 - 618
  • [34] Phase I pharmacokinetic and pharmacodynamic study of temozolomide in pediatric patients with refractory or recurrent leukemia: A children's oncology group study
    Horton, Terzah M.
    Thompson, Patrick A.
    Berg, Stacey L.
    Adamson, Peter C.
    Ingle, Ashish M.
    Dolan, M. Eileen
    Delaney, Shannon M.
    Hedge, Madhuri
    Weiss, Heidi L.
    Wu, Meng-Fen
    Blaney, Susan M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (31) : 4922 - 4928
  • [35] PHASE I STUDY OF VANDETANIB WITH RADIOTHERAPY AND TEMOZOLOMIDE FOR NEWLY DIAGNOSED GLIOBLASTOMA
    Drappatz, Jan
    Norden, Andrew D.
    Wong, Eric T.
    Doherty, Lisa M.
    LaFrankie, Debra C.
    Ciampa, Abigail
    Kesari, Santosh
    Sceppa, Christine
    Gerard, Mary
    Phan, Phuong
    Schiff, David
    Batchelor, Tracy T.
    Ligon, Keith L.
    Young, Geoffrey
    Muzikansky, Alona
    Weiss, Stephanie E.
    Wen, Patrick Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (01): : 85 - 90
  • [36] A phase I clinical trial of sonodynamic therapy combined with temozolomide in the treatment of recurrent glioblastoma
    Boya Zha
    Junping Yang
    Qianqian Dang
    Peihong Li
    Shuling Shi
    Jingjing Wu
    Haiyang Cui
    Linkuan Huangfu
    Yuxin Li
    Daoke Yang
    Yingjuan Zheng
    Journal of Neuro-Oncology, 2023, 162 : 317 - 326
  • [37] Cisplatin and Temozolomide in heavily pretreated and poor performance status (PS) patients with temozolomide refractory glioblastoma
    Lombardi, G.
    Zustovich, F.
    Carli, P.
    Della Puppa, A.
    Rotilio, A.
    Scienza, R.
    Pastorelli, D.
    EJC SUPPLEMENTS, 2009, 7 (02): : 498 - 498
  • [38] A phase I clinical trial of sonodynamic therapy combined with temozolomide in the treatment of recurrent glioblastoma
    Zha, Boya
    Yang, Junping
    Dang, Qianqian
    Li, Peihong
    Shi, Shuling
    Wu, Jingjing
    Cui, Haiyang
    Huangfu, Linkuan
    Li, Yuxin
    Yang, Daoke
    Zheng, Yingjuan
    JOURNAL OF NEURO-ONCOLOGY, 2023, 162 (2) : 317 - 326
  • [39] Phase II study of dose-intense temozolomide in recurrent glioblastoma.
    Hammond, S.
    Norden, A. D.
    Lesser, G. J.
    Drappatz, J.
    Fadul, C. E.
    Batchelor, T.
    Quant, E. C.
    Beroukhim, R.
    Muzikansky, A.
    Ciampa, A. S.
    Doherty, L. M.
    LaFrankie, D. C.
    Ruland, S.
    Bochacki, C. A.
    Griffin, K.
    Gerard, M.
    Sceppa, C.
    Rosenfeld, M. R.
    Wen, P. Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [40] A PHASE I STUDY OF SORAFENIB WITH RADIATION AND TEMOZOLOMIDE IN NEWLY DIAGNOSED GLIOBLASTOMA
    Colman, Howard
    Gilbert, Mark
    Yung, W. K. Alfred
    Aldape, Ken
    De Groot, John
    Conrad, Charles
    Levin, Victor
    Groves, Morris
    Loghin, Monica
    Chris, Pelloski
    Puduvalli, Vinay
    NEURO-ONCOLOGY, 2011, 13 : 61 - 61
12345